home / stock / tvrd / tvrd news


TVRD News and Press, Tvardi Therapeutics Inc.

Stock Information

Company Name: Tvardi Therapeutics Inc.
Stock Symbol: TVRD
Market: NASDAQ
Website: tvarditherapeutics.com

Menu

Get TVRD Alerts

News, Short Squeeze, Breakout and More Instantly...

TVRD - US Companies Moving the Markets, Evening edition
Thu, Jul 09, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X (SOXS) fell 9.6% to $4.07 on volume of 673,374,347 shares ProShares Bitcoin ETF (BITO) rose 1.5% to $8.57 on volume of 326,768,067 shares Edible Garden AG Incorporated (EDBL) rose 0.0% to $0.116 on v...

TVRD - TVRD Price Target Alert: $13.00. Issued by Piper Sandler

2026-07-08 17:15:02 ET from Piper Sandler issued a price target of $13.00 for TVRD on 2026-07-08 19:34:12. The adjusted price target was set to $13.00. At the time of the announcement, TVRD was trading at $5. The overall price target consensus is at $7.33 with high price...

TVRD - US Companies Moving the Markets, Evening edition
Wed, Jul 08, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X (SOXS) fell 6.2% to $4.5 on volume of 829,814,789 shares Edible Garden AG Incorporated (EDBL) rose 32.3% to $0.116 on volume of 465,321,464 shares Direxion Small Cap Bear 3X (TZA) rose 2.5% to $4.07 ...

TVRD - Overweight Recommendation Issued On TVRD By Piper Sandler

2026-07-08 16:15:04 ET Piper Sandler analyst issues OVERWEIGHT recommendation for TVRD on July 8, 2026 07:34PM ET. The previous analyst recommendation was Neutral. TVRD was trading at $5 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cur...

TVRD - Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prodrug Design, Tolerability and Target Engagement Transcript

2026-07-07 18:02:27 ET Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prodrug Design, Tolerability and Target Engagement July 7, 2026 8:30 AM EDT... Read the full article on Seeking Alpha For further details see: Tvardi Therap...

TVRD - US Companies Moving the Markets, Evening edition
Tue, Jul 07, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X (SOXS) rose 15.1% to $4.8 on volume of 673,079,062 shares Pop Culture Group Co. Ltd (CPOP) rose 10.4% to $0.1019 on volume of 397,952,535 shares Direxion Small Cap Bear 3X (TZA) rose 2.8% to $3.97 on...

TVRD - Tvardi Therapeutics (Nasdaq: TVRD) Soars on Positive Phase 1 Results for Next-Gen STAT3 Inhibitor TTI-109

2026-07-07 12:45:00 ET Published on Jul 7, 2026 Investorideas.com ( www.investorideas.com ) a trusted platform for investing ideas, including biotech and medical tech stocks, issues a news and trading alert for T...

TVRD - US Companies Moving the Markets, Morning edition
Tue, Jul 07, 2026 as of 10.00 am ET

A look at the top 10 most actives in the United States Pop Culture Group Co. Ltd (CPOP) rose 18.5% to $0.1094 on volume of 250,714,275 shares Direxion Daily Semiconductor Bear 3X (SOXS) rose 13.6% to $4.7378 on volume of 153,002,015 shares CCH Holdings Ltd (CCHH) rose 38.6% to $0.6234 on vo...

TVRD - Tvardi Therapeutics' TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement

TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell populations including Th17, T follicular helper (Tfh) and B cells Company plans to advance TTI-109 into STAT3-driven dermatologic and gastrointestina...

TVRD - US Companies Moving the Markets, Evening edition
Fri, Jun 26, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States INLIF LIMITED (INLF) rose 55.7% to $0.0467 on volume of 2,196,687,442 shares Direxion Daily Semiconductor Bear 3X (SOXS) rose 16.8% to $4.24 on volume of 674,265,171 shares GD Culture Group Limited (GDC) fell 13.1% to $0.0119 on volume ...

Next 10